跳至主要内容
临床试验/NCT01734668
NCT01734668已完成不适用

Sofia RSV FIA Field Study

Quidel Corporation17 个研究点 分布在 1 个国家目标入组 2,468 人开始时间: 2012年3月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
2,468
试验地点
17
主要终点
High level of sensitivity and specificity for performance vs. culture

研究概览

简要总结

The objective of this study is to demonstrate the clinical performance of the Sofia RSV FIA with specimens from symptomatic pediatric subjects who are less than nineteen (19) years of age.

研究设计

研究类型
Observational
时间视角
Prospective

入排标准

年龄范围
— 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Male or Female
  • Children less than nineteen (19) years of age can participate (assuming appropriate consent is obtained).
  • Must currently be exhibiting symptoms characteristic of respiratory syncytial virus (RSV) illness.
  • Subjects must present with one or more of the following to be eligible for enrollment:
  • Fever, ≥ 37.8º C (100º F) at present or within past 24 hours
  • Moderate to severe runny nose*
  • Moderate to severe congestion*
  • Decreased appetite
  • Sneezing*
  • Irritability
  • Decreased activity
  • Labored breathing

排除标准

  • Subjects nineteen years of age or older.
  • The parent or legal guardian is unable to understand and consent to participation.
  • Current or prior treatment during this infection with anti-RSV Synagis®.

结局指标

主要结局

High level of sensitivity and specificity for performance vs. culture

时间窗: Culture results within 48 hours of plating

Clinical performance will be based on comparison of the Sofia RSV FIA results to cell culture.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (17)

Loading locations...

相似试验